Karen B. Stockley’s drug interactions. 9th ed. London: Pharmaceutical Press; 2010.
Bolhuis MS, Panday PN, Pranger AD, et al. Pharmacokinetic drug interactions of antimicrobial drugs: a systematic review on oxazolidinones, rifamycins, macrolides, fluoroquinolones, and beta-lactams. Pharmaceutics. 2011;3(4):865–913.
Bjornsson T, Callaghan J, Einolf H, et al. Pharmaceutical research and manufacturers of America (PhRMA) drug metabolism/clinical pharmacology technical working group; FDA Center for drug evaluation and research (CDER). The conduct of in vitro and in vivo drug-drug interaction studies: PhRMAperspe. Drug Met Dispos. 2003;31(7):815–32.
Varma MV, Pang KS, Isoherranen N, Zhao P, et al. Dealing with the complex drug-drug interactions: towards mechanistic models. Biopharm Drug Dispos. 2015;36:71–92.
Diksis N, Melaku T, Assefa D, Tesfaye A, et al. Potential drug-drug interactions and associated factors among hospitalized cardiac patients at Jimma University medical center, Southwest Ethiopia. SAGE Open Med. 2019;7:1–9 https://doi.org/10.1177/2050312119857353.
Tesfay BT, Mega TA, Kebede TM, et al. Human Immunodeficiency Virus-Infected Patients on Highly Active Anti-Retroviral Therapy. Indo Am J Pharm Res. 2017;7(08):488–98.
Mezgebe HB, Seid K. Prevalence of potential drug-drug interactions among psychiatric patients in Ayder referral hospital, Mekelle, Tigray, Ethiopia. J Sci Innovative Res. 2015;4(2):71–5.
Wang JK, Herzog NS, Kaushal R, Park C, Mochizuki C, Weingarten S. Prevention of pediatric medication errors by hospital pharmacists and the potential benefit of computerized physician order entry. Pediatrics. 2007;119(1):e77–85. https://doi.org/10.1542/peds.2006-0034.
Heininger-Rothbucher D, Bischinger S, Ulmer H, Pechlaner C, Speer G, Wiedermann CJ. Incidence and risk of potential adverse drug interactions in the emergency room. Resuscitation. 2001;49:283–8.
Ko Y, Malone DC, Skrepnek GH, Armstrong EP, Murphy JE, Abarca J, Rehfeld RA, Reel SJ, Woosley RL, et al. Prescribers’ knowledge of and sources of information for potential drug-drug interactions: a postal survey of US prescribers. Drug Saf. 2008;31:525–36.
Alessandra B, Natália M, Fernando A, Rogério B. Identifying potential drug interactions in chronic kidney disease patients. J Bras Nefrol. 2014;36(1):26–34. https://doi.org/10.5935/0101-2800.20140006.
Palatini P, De Martin S. Pharmacokinetic drug interactions in liver disease: an update. World J Gastroenterol. 2016;22(3):1260–78 https://doi.org/10.3748/wjg.v22.i3.1260.
Gallelli L, Antonio S, Caterina P, Laura M, Orietta S, Aida S, Francesca M, Emilio R, Santo G, Giovambattista D. Adverse drug reactions related to drug Administration in Hospitalized Patients. Curr Drug Saf. 2017;12(3):171–7. https://doi.org/10.2174/1574886312666170616090640.
Janković SM, Pejčić AV, Milosavljevic MN, et al. Risk factors for potential drug-drug interactions in intensive care unit patients. J Crit Care. 2018;43:1–6.
Obreli-Neto PR, Nobili A, de Oliveira BA, et al. Adverse drug reactions caused by drug-drug interactions in elderly outpatients: a prospective cohort study. Euro J Clin Pharmacol. 2012;68(12):1667–76.
Romagnoli KM, Nelson SD, Hines L, et al. Information needs for making clinical recommendations about potential drug-drug interactions: a synthesis of literature review and interviews. BMC Med Inform DecisMak. 2017;17(1):21.
Zwart-van-Rijkom JEF, Uijtendaal EV, Ten Berg MJ, Van Solinge WW, Egberts AC. Frequency and nature of drug-drug interactions in a Dutch university hospital. Br J Clin Pharmacol. 2009;68:187–93.
Nasuhara Y, Sakushima K, Endoh A, et al. Physicians’ responses to computerized drug interaction alert with password override. BMC Med Inform Decis Mak. 2015;15:74.
Qorraj-Bytyqi H, Hoxha R, Krasniqi S, Bahtiri E, Kransiqi V, et al. The incidence and clinical relevance of drug interaction in pediatrics. J Pharmacol Pharmacother. 2012;3:304–7.
Kothari N, Gaguly B. Potential drug-drug interactions among medications prescribed to hypertensive patients. J Clin Disgn Res. 2014;8(11):1–4.
Berha AB, Seyoum N. Evaluation of drug prescription pattern using world health organization prescribing indicators in Tikur Anbessa specialized hospital: a cross-sectional study. J Drug Deliv Ther. 2018;8(1):74–8.
Sisay M, Mengistu G, Molla B, Amare F, Gabriel T, et al. Evaluation of rational drug use based on World Health Organization Core drug use indicators in selected public hospitals of eastern Ethiopia : a cross-sectional study. BMC Health Serv Res. 2017;17(161):1–9.
Liberati A. The PRISMA Statement for Reporting Systematic Reviews and MetaAnalyses of Studies That Evaluate Health Care Interventions. Explanation Elaboration. 2009;6(7):e1000097.
Nabovati E, Vakili-Arki H, Taherzadeh Z, Reza Hasibian M, Abu-Hanna A, Eslami S, et al. Drug-drug interactions in inpatient and outpatient settings in Iran: a systematic review of the literature. DARU J Pharm Sci. 2014;22(1):52. https://doi.org/10.1186/2008-2231-22-52.
Gunasekaran T, Dejene N, Satyaveni VV, Dhanaraju MD, et al. Occurrence of drug-drug interactions in Adama referral hospital, Adama city, Ethiopia. J Drug Assess. 2016;4:19–23 https://doi.org/10.3109/21556660.2015.1067218.
Chelkeba L, Alemseged F, Bedada W, et al. Assessment of potential drug-drug interactions among outpatients receiving cardiovascular medications at Jimma University specialized hospital, south West Ethiopia. Int J Basic Clin Pharmacol. 2013;2(2):144–52.
Bhagavathula AS, Berhanie A, Tigistu H, Abraham Y, Getachew Y, Khan TM, Unkal C, et al. Prevalence of potential drug-drug interactions among internal ward in University of Gondar Teaching Hospital, Ethiopia medicine. Asian Pac J Trop Biomed. 2014;4(1):204–8 https://doi.org/10.12980/APJTB.4.2014C1172.
Admassie E, Melese T, Mequanent W, Hailu W, Srikanth BA, et al. Extent of poly-pharmacy, occurrence, and associated factors of drug-drug interaction and potential adverse drug reactions in Gondar teaching referral hospital. J Adv Pharm Technol Res. 2013;4(4):183–9 https://doi.org/10.4103/2231-4040.121412.
Getachew H, Assen M, Dula F, Bhagavathula AS, et al. Potential drug-drug interactions in pediatric wards of Gondar University hospital, Ethiopia: a cross-sectional study. Asian Pac J Trop Biomed. 2016;6(6):534–8 https://doi.org/10.1016/j.apjtb.2016.04.002.
Teka F, Teklay G, Ayalew E, Teshome T, et al. Potential drug-drug interactions among elderly patients admitted to the medical ward of Ayder referral hospital, northern Ethiopia: a cross-sectional study. BMC Res Notes. 2016;1(9):431.
Gebretsadik Z, Gebrehans M, Getnet D, Gebrie D, Alema T, Belay YB. Assessment of drug-drug interaction in Ayder comprehensive specialized hospital, Mekelle, Northern Ethiopia: A Retrospective Study. BioMed Res Int. 2017. https://doi.org/10.1155/2017/9792363.
Teklay G, Shiferaw N, Legesse B, Bekele ML, et al. Drug-drug interactions and risk of bleeding among inpatients on warfarin therapy: a prospective observational study. Thromb J. 2014;12(1):1–8 https://doi.org/10.1186/1477-9560-12-20.
Yesuf TA, Belay AZ, Sisay EA, Gebreamlak ZB, et al. Prevalence and Clinical Significance of Potential Drug-Drug Interactions at Ayder Referral Hospital, Northern Ethiopia. J Dev Drugs. 2017;6(3) https://doi.org/10.4172/2329-6631.1000179.
Tesfaye ZT, Teshome N. Potential drug-drug interactions in inpatients treated at the internal medicine ward of Tikur Anbessa specialized hospital. Drug Healthc Patient Saf. 2017;9:71–6.
Kibrom S, Tilahun Z, Huluka SA, et al. Potential drug-drug interactions among adult patients admitted to medical wards at a tertiary teaching hospital in Ethiopia. J Drug Deliv Ther. 2018;8(5):348–54.
Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication Bias. Biometrics. 1994;50(4):1088.
Laird N, DerSimonian R. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.
Higgins JP, Julian PT. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58. https://doi.org/10.1002/sim.1186.
Zheng WY, Richardson LC, Ling L, Day RO, Westbrook JI, Baysar MT, et al. Drug-drug interactions and their harmful effects in hospitalized patients: a systematic review and meta-analysis. Eur J Clin Pharmacol. 2018;74(1):15–27 https://doi.org/10.1007/s00228-017-2357-5.
Kohler GI, Bode-Boger SM, Busse R, Hoopmann M, Welte T, Boger RH, et al. Drug-drug interactions in medical patients: effects of in-hospital treatment and relation to multiple drug use. Int J Clin Pharmacol Ther. 2000;38(11):504–13.
Espinosa-Bosch M, Bernardo SR, Maria VG, Maria DS, Roberto MG, et al. Prevalence of drug interactions in hospital healthcare. Int J Clin Pharm. 2012;34(6):807–17. https://doi.org/10.1007/s11096-012-9697-0.
Kashyap M, D’Cruz S, Sachdev A, Tiwari P. Drug-drug interactions and their predictors: results from Indian elderly inpatients. Pharm Pract. 2013;11(4):191–5.
Ibielli P, Rozenfeld S, Matos GC, FdeAcurcio A. Potential drug-drug interactions among the elderly using antihypertensives from the Brazilian list of essential medicines. Cad Saude Pub. 2014;30(9):1947–56.